In conclusion, these studies have shown that genetic inhibition of ACLY in MASH-driven mouse models of HCC promotes the infiltration of tumour-infiltrating B cells and that this is critical for reducing tumour burden. Here, ACLY is linked to hepatocellular carcinoma.